Human Health Project’s Real-World Data program is a significant platform that shares surveyed healthcare information to the public. The data collected is helpful to the public to help individuals make informed healthcare decisions. The data collected by HHP’s Real-World Data program applies to surveys collected for various health factors, including, Causes, Symptoms, Over the Counter Treatments, Prescription Treatments, as well as additional factors. Ultimately, it is important to understand how HHP’s Real-World Data program works, in order to see how it can be used for a range of illnesses.                                                                                                                                               

The survey data that has been collected for migraine headaches by the Real-World Data program demonstrates its effectiveness. With regards to the category Symptoms and its subcategory Frequency for migraine headaches, 47.4% of surveyees reported they experienced less than five migraines per month. 22.6% of surveyees reported experiencing 6-10 migraines per month, 9.3 % reported experiencing 11-15 migraines per month, 13.1 % reported more than 15 migraines per month, and 7.7% experiencing no migraines per month. This data is relevant in that while many of the surveyees did not report frequent migraines, there was still a substantial percentage, 45%, reporting frequent migraine headaches per month.                                                                                             

In addition, the Real-World Data program can be successfully measured by analyzing the data for over the counter treatments, which has yielded significant data. With regards to over the counter treatments, regarding the question, “Have you ever used any of the following over the counter (OTC) treatments for your migraine headaches?” the majority of surveyees, 69.7%, indicated that they have used Ibuprofen to help treat migraine headaches. In addition, 40.5% of surveyees used Aspirin, 23.7% used Tylenol, 22.3% used Naproxen, 18.5% used a combination of Acetaminophen, Aspirin, and Caffeine, and 12.9% used Caffeine. Thus, while the majority of surveyees expressed confidence in taking Ibuprofen, it is important to note that additional over the counter medications still indicate a substantial percentage of the treatments used for migraine headaches, and yields relevant and significant data. Ultimately, the survey data collected for both frequency of symptoms, as well as over the counter treatments, represents the significance and overall effectiveness of the Real-World Data program in response to the surveys collected. 

The response to the survey data has also been considerably positive. 78.2% of responders said that it was at least easy to navigate the Migraine Headache survey data. Additionally, 91.4% of respondents rated the overall organization of the Migraine Headache survey data results at least good. 71.7% of respondents would also recommend that a family member or friend view the survey data, if a family member or friend were experiencing migraine headaches. 68.4% found that the information provided in the Migraine Headache results was useful or better. Finally, 54.3% of the respondents said that they plan to use what they have learned from the Migraine Headache survey results to help himself or herself, or help someone that the respondents care for, to better manage migraine headaches. These high percentages recorded that indicate the successful feedback of the Real-World Data program surveys, also show how the program would be successful to a wide range of people.  

The Real-World Data program has already been effective on migraines, but would additionally be effective on a range of illnesses that can also yield data, such as influenza. As influenza in particular is a seasonal disease, this illness would likely generate high survey responses regarding frequency of symptoms, as well as over the counter treatments. By collecting surveys to help in analyzing data, factors including symptoms and treatments can be collected for a range of illnesses, that can yield relevant data.

To conclude, the functions of HHP’s Real-World Data program are important to understand in order to see how the Real-World Data program can be effective. The survey data on migraine headaches, as well as the responses to the survey data, indicate the effectiveness of the Real-World Data program. While the Real-World Data program has been tailored to migraine headaches, it is evident that the program would be effective on a range of illnesses, including seasonal illnesses such as influenza that can produce significant data. The Real-World Data program has already proven to be effective, and through continuing to collect survey data on a range of illnesses, it will be even more useful in the future. 

Call to Action: More information can be learned about HHP’s Real-World Data program at: https://humanhealthproject.org/hhp-real-world-data-program/